Skip to main content
. 2014 Oct 2;15(1):841. doi: 10.1186/1471-2164-15-841

Table 3.

Survival analysis of rrf-3 mutants treated with RNAi against DHHCs and PPTs

RNAi strain n Mean (days) Median (days) 90% mortality (days) Maximum (days)
L4440 208 16 16 25 31
dhhc-1 79 16 16 24 25
dhhc-11 47 12* 10 18 21
dhhc-14 99 19 19 22 31
spe-10 79 18 19 24 29
ppt-1 108 13 12 23 30
ath-1 47 16 16 25 26
RNAi strain(s) n Mean (days) Median (days) 90% mortality (days) Maximum (days)
L4440 208 16 17 25 31
dhhc-1 + dhhc-10 50 18 18 24 29
dhhc-2 + dhhc-8 50 13* 13 20 24
dhhc-3 + dhhc-7 23 19 20 26 28
dhhc-4 + spe-10 34 21* 21 27 33
dhhc-5 + dhhc-6 27 17 16 25 26
dhhc-9 + dhhc-12 44 18 18 24 26
dhhc-13 + dhhc-14 38 21 21 24 30
ppt-1 + ath-1 143 14* 14 23 30

Various measures of survival were extracted from lifespan experiments comparing hypersensitive rrf-3 animals treated with feeding RNAi empty vector L4440 control or against DHHC or PPT mutant strains (top). Mixtures of feeding RNAi bacteria were also used to assess simultaneous knockdown of related enzymes (bottom). Statistical tests were applied to values varying from the control using OASIS [73]. *p < 0.01 by the log-rank (Mantel-Cox) test. p < 0.01 by Fisher’s exact test.r.